Amedisys, Inc.
Amedisys, Inc. (AMED) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AMED · as of Jun 9, 2026
Key Statistics
Explore Amedisys, Inc. Data
amed stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 28 · Buy rate: 28.6%
The AMED analyst consensus is Hold, based on ratings from 28 Wall Street analysts over the past 3 months. The average 12-month price target is $143.38, representing +41.97% upside from the current price of $100.99.
Competitors & Peers
amed competitorsAMED
ASTH
AXNX
CBAY
LHCG
MORStock Performance
Full HistoryAbout Amedisys, Inc.
Amedisys, Inc. along with its various subsidiaries, delivers a spectrum of healthcare solutions throughout the United States. Its operations are structured across four distinct divisions: Home Health…
what is amedisys, inc. · amed stock overview · amedisys, inc. company profile · who is amedisys, inc. ceo · amed NASDAQ · amedisys, inc. headquarters · amedisys, inc. business segments
About Stock Overview & Key Data
Amedisys, Inc. (AMED) is a Healthcare company in the Medical - Care Facilities industry, listed on NASDAQ since Aug 17, 1994. As of the latest trading session, AMED stock price is $100.99, with a market capitalization of $3.3B. The stock has returned +4.21% over the past 12 months and +11.10% year-to-date.
According to 28 Wall Street analysts, the consensus rating for Amedisys, Inc. stock is Hold, with an average 12-month price target of $143.38. In fiscal year 2024, Amedisys, Inc. reported revenue of $2.3B and net income of $43.2M. For detailed data — including Amedisys, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Amedisys, Inc. (AMED) stock price is $100.99. The stock is traded on NASDAQ under the ticker symbol AMED. The 52-week range is $82.15 – $101.02.